Neuroinformatics

BMO Marks World Mental Health Day with $5 Million to CAMH to Drive Innovation in Research for Mental Health

Retrieved on: 
Wednesday, October 11, 2023

TORONTO, Oct. 11, 2023 /CNW/ - BMO marked World Mental Health Day this year with a $5 million donation to the Centre for Addiction and Mental Health (CAMH) in Toronto.

Key Points: 
  • TORONTO, Oct. 11, 2023 /CNW/ - BMO marked World Mental Health Day this year with a $5 million donation to the Centre for Addiction and Mental Health (CAMH) in Toronto.
  • Together with CAMH, BMO's donation will help people living with mental illness by accelerating research and access to world-class mental health care through four strategic priorities: neuroinformatics, digital health innovation, education, and research.
  • "We are grateful to BMO for their continued support of CAMH and life-saving mental health research," said Deborah Gillis, President & CEO, CAMH Foundation.
  • October 10 is World Mental Health Day, an international day for global mental health education, awareness and advocacy against social stigma.

Center for BrainHealth Receives Transformational Investment from Sammons Enterprises, Names Imaging Center

Retrieved on: 
Wednesday, April 6, 2022

The multi-year gift from Sammons Enterprises will turbo-charge the Centers ability to pioneer, test and deliver novel metrics that assess gains in brain health and performance.

Key Points: 
  • The multi-year gift from Sammons Enterprises will turbo-charge the Centers ability to pioneer, test and deliver novel metrics that assess gains in brain health and performance.
  • In recognition of this transformational investment in the future of BrainHealth, the Centers state-of-the-art imaging facility will be named the Sammons BrainHealth Imaging Center.
  • With the Sammons gift, the UTD Center for BrainHealth has reached more than 60% of the $50 million goal for its comprehensive campaign, currently in its silent phase.
  • Translational innovations build on Strategic Memory Advanced Reasoning Tactics (SMART), a proprietary methodology developed and tested by BrainHealth researchers and other teams over three decades.

Biomax Informatics : Universities use NeuroXM™ to study the connectome in drug-resistant epilepsy

Retrieved on: 
Thursday, May 20, 2021

b'Using Biomax Informatics\' NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change in the connectome in drug-resistant epilepsy patients.

Key Points: 
  • b'Using Biomax Informatics\' NeuroXM knowledge management platform, scientists from the Universities of Nottingham, Newcastle, Qingdao, Shanghai and Munich have studied the change in the connectome in drug-resistant epilepsy patients.
  • This connectivity network could then be visualized and accessed via the web portal of NICARA\xe2\x84\xa2, the neuroimaging solution offered by Biomax.
  • "Our experience shows us that our software can be easily deployed in hospitals," explained project leader Dr. Markus Butz-Ostendorf of Biomax.
  • Marcus Kaiser, Professor of Neuroinformatics at the University of Nottingham, confirms, "The use of NeuroXM and NICARA is central to this research project.

Brain Armor Announces Nationwide Distribution with Whole Foods Market

Retrieved on: 
Monday, August 31, 2020

Brain Armor offers a range of clinically-proven supplements formulated to support the brain at every stage of life through targeted neuro-nutrition.

Key Points: 
  • Brain Armor offers a range of clinically-proven supplements formulated to support the brain at every stage of life through targeted neuro-nutrition.
  • This nationwide listing with Whole Foods reflects the significant investment Brain Armor has made in both clinical research and product formulation.
  • The confidence in the Brain Armor brand has led to numerous partnerships with elite athletes, professional sports teams and organizations such as the NFL Alumni, said Scott Chapman, President, Trident Brands Inc. Our entire team is very excited to extend Brain Armor availability and advance our mission to improve brain health in partnership with Whole Foods Market.
  • Brain Armor is on a mission to improve cognitive health, well-being and performance at every stage of life and on every field of play.

Allen Institute Announces New Phase Of Neuroscience Research

Retrieved on: 
Monday, April 6, 2020

SEATTLE, April 6, 2020 /PRNewswire/ -- The Allen Institute today announced new phases of research for its largest division, the Allen Institute for Brain Science, as well as a leader hired to direct a new neuroscience-related division of the Institute.

Key Points: 
  • SEATTLE, April 6, 2020 /PRNewswire/ -- The Allen Institute today announced new phases of research for its largest division, the Allen Institute for Brain Science, as well as a leader hired to direct a new neuroscience-related division of the Institute.
  • Established in 2003, the Allen Institute for Brain Science has grown to more than 300 researchers and staff working in two broad research programs.
  • In this new phase, the Allen Institute for Brain Science will focus solely on brain cell types and connectivity research.
  • The MindScope Program, which seeks to understand how the brain's neural circuits produce the sense of vision, will also move into a new phase of discovery and will transition out of the Allen Institute for Brain Science to become a separate program of the Allen Institute.

More Than Half Of U.S. Workers Are Anxious; 34 % Are Looking To Employers To Help Quell COVID-19-Driven Anxiety

Retrieved on: 
Wednesday, March 18, 2020

These findings were announced today by Total Brain , the neuroscience-based mental health and wellness digital platform that commissioned the research.

Key Points: 
  • These findings were announced today by Total Brain , the neuroscience-based mental health and wellness digital platform that commissioned the research.
  • With 34 percent of survey respondents stating that they are looking to their employer for resources to help quell their anxiety, Total Brain is offering qualified U.S. companies a free three-month subscription to its employee mental health and wellness platform at no cost.
  • "At Total Brain, we are committed to sharing our core neuroscientific capabilities to help mitigate the mental health fallout from the COVID-19 pandemic," explained Louis Gagnon, CEO, Total Brain.
  • "Through our research, we learned that two in five employees do not have access to workplace mental health resources.

The Krembil Centre for Neuroinformatics introduces its international team of scientists

Retrieved on: 
Thursday, June 13, 2019

TORONTO, June 13, 2019 /PRNewswire/ -The Centre for Addiction and Mental Health (CAMH) is pleased to introduce its international team of scientists at the Krembil Centre for Neuroinformatics.

Key Points: 
  • TORONTO, June 13, 2019 /PRNewswire/ -The Centre for Addiction and Mental Health (CAMH) is pleased to introduce its international team of scientists at the Krembil Centre for Neuroinformatics.
  • It will be used by the neuroinformatics centre for future research to benefit patients at CAMH and around the world.
  • The multidisciplinary team of international scientists includes:
    The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital and a world leading research centre in this field.
  • CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre.

Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting

Retrieved on: 
Thursday, April 11, 2019

The BRAIN InitiativeInvestigators Meeting convenes BRAIN Initiative awardees, staff, and leadership from the contributing federal agencies (NIH, NSF, DARPA, IARPA, and FDA), plus representatives and investigators from participating non-federal organizations.

Key Points: 
  • The BRAIN InitiativeInvestigators Meeting convenes BRAIN Initiative awardees, staff, and leadership from the contributing federal agencies (NIH, NSF, DARPA, IARPA, and FDA), plus representatives and investigators from participating non-federal organizations.
  • We are encouraged by the progress Orion subjects are making on visual function endpoints like square localization and direction of motion.
  • Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals.
  • We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made.